terms |
epratuzumab |
As nouns the difference between terms and epratuzumab
is that
terms is while
epratuzumab is a humanized monoclonal antibody with potential applications in oncology and in the treatment of inflammatory autoimmune disorders such as lupus.
lupus |
epratuzumab |
As a noun epratuzumab is
a humanized monoclonal antibody with potential applications in oncology and in the treatment of inflammatory autoimmune disorders such as lupus.
disorder |
epratuzumab |
As nouns the difference between disorder and epratuzumab
is that
disorder is absence of order; state of not being arranged in an orderly manner while
epratuzumab is a humanized monoclonal antibody with potential applications in oncology and in the treatment of inflammatory autoimmune disorders such as lupus.
autoimmune |
epratuzumab |
As an adjective autoimmune
is of or pertaining to autoimmunity.
As a noun epratuzumab is
a humanized monoclonal antibody with potential applications in oncology and in the treatment of inflammatory autoimmune disorders such as lupus.
inflammatory |
epratuzumab |
As nouns the difference between inflammatory and epratuzumab
is that
inflammatory is any material that causes inflammation while
epratuzumab is a humanized monoclonal antibody with potential applications in oncology and in the treatment of inflammatory autoimmune disorders such as lupus.
As an adjective inflammatory
is tending to inflame or provoke somebody.
oncology |
epratuzumab |
As nouns the difference between oncology and epratuzumab
is that
oncology is the branch of medicine concerned with tumors, including study of their development, diagnosis, treatment, and prevention while
epratuzumab is a humanized monoclonal antibody with potential applications in oncology and in the treatment of inflammatory autoimmune disorders such as lupus.
humanized |
epratuzumab |
As a verb humanized
is (
humanize).
As a noun epratuzumab is
a humanized monoclonal antibody with potential applications in oncology and in the treatment of inflammatory autoimmune disorders such as lupus.